MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,105,000 | -18.0% | 783,256 | -48.0% | 0.02% | -22.7% |
| Q2 2020 | $50,113,000 | +17.2% | 1,506,022 | -4.2% | 0.02% | 0.0% |
| Q1 2020 | $42,773,000 | +37.1% | 1,572,421 | -0.6% | 0.02% | +100.0% |
| Q4 2019 | $31,208,000 | +50.4% | 1,581,812 | -1.2% | 0.01% | +37.5% |
| Q3 2019 | $20,756,000 | +6.2% | 1,601,364 | +2.0% | 0.01% | 0.0% |
| Q2 2019 | $19,553,000 | +20.4% | 1,570,543 | +40.6% | 0.01% | +33.3% |
| Q1 2019 | $16,234,000 | +31.4% | 1,117,264 | -0.1% | 0.01% | 0.0% |
| Q4 2018 | $12,353,000 | -53.7% | 1,118,942 | +10.2% | 0.01% | -40.0% |
| Q3 2018 | $26,707,000 | +28.4% | 1,015,468 | -0.2% | 0.01% | +25.0% |
| Q2 2018 | $20,807,000 | +12.4% | 1,017,476 | -0.2% | 0.01% | 0.0% |
| Q1 2018 | $18,511,000 | +27.1% | 1,019,867 | -2.3% | 0.01% | +33.3% |
| Q4 2017 | $14,569,000 | +11.9% | 1,044,342 | +48.3% | 0.01% | 0.0% |
| Q3 2017 | $13,025,000 | +3.3% | 704,031 | -5.7% | 0.01% | 0.0% |
| Q2 2017 | $12,614,000 | +30.1% | 746,397 | +2.7% | 0.01% | +20.0% |
| Q1 2017 | $9,699,000 | -11.4% | 726,515 | -0.1% | 0.01% | 0.0% |
| Q4 2016 | $10,948,000 | -1.6% | 727,425 | -23.6% | 0.01% | -16.7% |
| Q3 2016 | $11,125,000 | +7.7% | 951,660 | -0.5% | 0.01% | 0.0% |
| Q2 2016 | $10,333,000 | +16.8% | 956,723 | -0.1% | 0.01% | +20.0% |
| Q1 2016 | $8,849,000 | -38.0% | 957,669 | -0.4% | 0.01% | -44.4% |
| Q4 2015 | $14,268,000 | -9.6% | 961,474 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $15,778,000 | -34.2% | 961,474 | -8.5% | 0.01% | -33.3% |
| Q2 2015 | $23,962,000 | +47.6% | 1,050,498 | -1.7% | 0.02% | +50.0% |
| Q1 2015 | $16,236,000 | +25.6% | 1,068,129 | -0.5% | 0.01% | +25.0% |
| Q4 2014 | $12,927,000 | +5.6% | 1,073,710 | -0.5% | 0.01% | -11.1% |
| Q3 2014 | $12,241,000 | -8.5% | 1,079,486 | -2.6% | 0.01% | 0.0% |
| Q2 2014 | $13,385,000 | +9.3% | 1,108,099 | +5.4% | 0.01% | 0.0% |
| Q1 2014 | $12,249,000 | -33.7% | 1,050,977 | +0.6% | 0.01% | -35.7% |
| Q4 2013 | $18,464,000 | +16.7% | 1,044,296 | -5.0% | 0.01% | 0.0% |
| Q3 2013 | $15,825,000 | +13.8% | 1,099,709 | +19.1% | 0.01% | +7.7% |
| Q2 2013 | $13,909,000 | – | 923,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
| Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
| Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
| Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
| Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
| Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
| Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |